Non-hypercalcemic pharmacological aspects of vitamin D analogs

Biochemical Pharmacology

Volumn 50, Issue 5, 1995, Pages 577-583

  Bouillon, Roger ^a   Verstuyf, Annemieke ^a   Verlinden, Lieve ^a   Allewaert, Katrien ^a   Branisteanu, Dumitri ^a   Mathieu, Chantal ^a   Van Baelen, Hugo ^a  

^a LEGENDO   (Belgium)

Author keywords

autoimmune diseases; cancer; psoriasis; vitamin D; vitamin D analogs

Indexed keywords

16 ENE 23 YNE 1,25 DIHYDROXYCOLECALCIFEROL; 22 OXACALCITRIOL; CALCIPOTRIOL; CALCITRIOL; G 1500; LEXACALCITOL; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

AUTOIMMUNITY; CANCER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; VITAMIN D METABOLISM;

ANIMAL; CALCITRIOL; HORMONES; HUMAN; HYPERCALCEMIA;

EID: 0029080966     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)00121-F     Document Type: Note

References (39)

1. Experimental investigation on rickets
2. Remembrance: Discovery of the vitamin D endocrine system
3. Physiology of the steroid-thyroid nuclear receptor superfamily
4. Newly identified actions of the vitamin D endocrine system.
5. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential.
6. 3 receptors: Structure and function in transcription
7. Evaluation of a putative vitamin D response element in the avian calcium binding protein gene
8. 3
9. Regulation of keratinocyte growth, differentiation, and vitamin-D metabolism by analogs of 1,25-dihydroxyvitamin-D
10. 3
11. Immunological properties of vitamin D analogues and metabolites
12. 3 analogues: A novel class of potent regulators of cell growth and immune responses
13. Vitamin-D analogs with low affinity for the vitamin-D binding protein. Enhanced in vitro and decreased in vivo activity
14. On the mechanisms for the selective action of vitamin D analogs
15. 3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses
16. 3
17. 3 or its derivatives
18. Activity of vitamin D analogs in co-transfected cos-7 cells
19. 3 and its 20-epimers
20. Potentialisation of vitamin D (analogs) by cytochrome P-450 enzyme inhibitors is analog- and cell-type specific
21. 3 is due to reduced catabolism and altered protein binding
22. 3 analogues in psoriasis. Clinical use and mode of action
23. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
24. Vitamin D and cancer: New insight into vitamin D physiology and potential for cancer therapy
25. 3 in MCF-7 breast
26. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene
27. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice
28. 16-cholecalciferol
29. 3, KH1060
30. 3 on the induction of experimental autoimmune thyroiditis
31. Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: Elevated mrna transcripts, protein synthesis, and accumulation in bone of mutant animals
32. 3
33. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis
34. 3
35. 3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice
36. 3